Cutsem EV, Martinelli E, Cascinu S, Sobrero A, Banzi M, Seitz J, et al. Regorafenib for patients with metastatic colorectal cancer who progressed afterstandard therapy: Results of the Large, single-arm, open-label phase IIIbCONSIGN study. Oncologist (2019) 24(2):185 –92.